We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.36%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.8B
AUM Growth
-$2.48B
(-5%)
Cap. Flow
-$831M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$130M |
| 2 |
Amgen
AMGN
|
+$96.1M |
| 3 |
Progressive
PGR
|
+$94.9M |
| 4 |
AbbVie
ABBV
|
+$77.1M |
| 5 |
Kenvue
KVUE
|
+$75.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$148M |
| 2 |
Johnson & Johnson
JNJ
|
+$147M |
| 3 |
LyondellBasell Industries
LYB
|
+$108M |
| 4 |
Dollar General
DG
|
+$91.2M |
| 5 |
ExxonMobil
XOM
|
+$87.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.48% |
| 2 | Healthcare | 17.42% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Communication Services | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
AbbVie
ABBV
$458B
| $348M | 0.74% |
2,336,585
+525,155
| +29% | +$77.1M |
|
27
Danaher
DHR
$135B
| $346M | 0.74% |
1,574,242
+290,542
| +23% | +$64.8M |
|
28
Adobe
ADBE
$89.5B
| $325M | 0.69% |
636,587
+15,937
| +3% | +$8.36M |
|
29
Applied Materials
AMAT
$426B
| $317M | 0.68% |
2,288,833
-333,110
| -13% | -$47.8M |
|
|
30
Eli Lilly
LLY
$1.07T
| $316M | 0.67% |
588,219
-288,166
| -33% | -$148M |
|
31
ServiceNow
NOW
$102B
| $304M | 0.65% |
2,719,285
-32,725
| -1% | -$3.73M |
|
32
Air Products & Chemicals
APD
$66.3B
| $295M | 0.63% |
1,039,382
-46,601
| -4% | -$13.7M |
|
33
Intercontinental Exchange
ICE
$82.4B
| $293M | 0.63% |
2,662,020
+153,073
| +6% | +$17.5M |
|
34
Humana
HUM
$46.7B
| $293M | 0.62% |
601,452
+38,724
| +7% | +$18.2M |
|
35
Mondelez International
MDLZ
$77.7B
| $288M | 0.61% |
4,147,161
+93,908
| +2% | +$6.77M |
|
36
O'Reilly Automotive
ORLY
$72.4B
| $283M | 0.6% |
4,676,025
+440,760
| +10% | +$27.6M |
|
37
NextEra Energy
NEE
$187B
| $272M | 0.58% |
4,741,779
-79,962
| -2% | -$5.54M |
|
38
Gilead Sciences
GILD
$161B
| $268M | 0.57% |
3,578,700
-62,976
| -2% | -$4.84M |
|
39
Vertex Pharmaceuticals
VRTX
$121B
| $263M | 0.56% |
755,502
-11,990
| -2% | -$4.19M |
|
40
Kinder Morgan
KMI
$73.1B
| $263M | 0.56% |
15,833,103
-3,822
| -0% | -$65.9K |
|
41
Costco
COST
$415B
| $259M | 0.55% |
458,286
-13,568
| -3% | -$7.49M |
|
42
Texas Instruments
TXN
$255B
| $257M | 0.55% |
1,614,437
-379,151
| -19% | -$64.7M |
|
43
Enterprise Products Partners
EPD
$83.8B
| $253M | 0.54% |
9,252,060
| – | – |
|
44
Analog Devices
ADI
$181B
| $251M | 0.54% |
1,431,135
-316,144
| -18% | -$58.3M |
|
45
Southern Company
SO
$110B
| $246M | 0.53% |
3,808,015
-58,107
| -2% | -$4.03M |
|
46
Stryker
SYK
$127B
| $244M | 0.52% |
892,729
-46,565
| -5% | -$13.4M |
|
47
Duke Energy
DUK
$102B
| $235M | 0.5% |
2,667,356
-11,769
| -0.4% | -$1.08M |
|
48
Honeywell
HON
$77.1B
| $230M | 0.49% |
1,320,174
+932
| +0.1% | +$171K |
|
49
Intuitive Surgical
ISRG
$121B
| $229M | 0.49% |
783,928
+104,865
| +15% | +$32.7M |
|
|
SCHW
50
Charles Schwab
SCHW
$177B
| $227M | 0.49% |
4,138,805
+1,045,931
| +34% | +$63.2M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Ensign Peak Advisors held 1,786 positions worth $46.8B, down 5% from $49.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 3.1%. Ensign Peak Advisors opened 25 new positions and exited 30, leaving the 1,786-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2023 buy was Invesco QQQ Trust: 160,000 shares worth $57.3M.
- Ensign Peak Advisors added most to Crown Castle in Q3 2023, an estimated $130M increase.
- Ensign Peak Advisors's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $148M.
- Ensign Peak Advisors fully exited RB Global in Q3 2023, selling an estimated $26.5M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $46.8B portfolio in Q3 2023.
- Ensign Peak Advisors opened 25 new positions and closed 30 in Q3 2023.
- Ensign Peak Advisors's portfolio value fell 5% quarter-over-quarter to $46.8B.
Based on Ensign Peak Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.